Skip to main content

Welcome to the CRL Insurer Services blog. From big data and insurtech to accelerated underwriting and self-service products, the world of life insurance is moving at an unprecedented pace. We are confident that mortality data and insurance industry capabilities will continue to evolve, and seek to provide relevant expertise and updates to our valued clients.

As we continue to provide lab, data, and underwriting services through the CRL Insurers Business Unit, we look forward to sharing updates with you here. Check out the latest posts below from our dedicated team of medical directors and industry leaders, who provide commentary on timely topics, innovative services and solutions, and the existing database of CRL expertise.

 

COVID-19 Long-Haul Effects

August 5, 2021

CRL Chief Scientific Officer Dr. Robert Stout discusses the lasting impact of COVID-19 infection in both symptomatic and asymptomatic patients…. Read More

Tags: Covid 19, Covid 19 Crisis, Laboratory, Life Insurance, Mortality

Coming Soon: A Weekly Shot to Control Obesity

July 14, 2021

By 2018, over 42% of US adults were obese (BMI 30+) with little variation by age and sex, and almost… Read More

Tags: Bmi, Insurance, Life Insurance, Obesity, Type 2 Diabetes

Recent Publication on Mortality: Impacts on Insurers

June 28, 2021

Recently Dr. Michael Fulks commented on 2020 mortality data from JAMA, citing an increase of 17.7% from 2019 to 2020… Read More

Tags: Cancer, Insurance, Life Insurance, Mortality, Retirement

2020 US Mortality Results: How do they compare to prior years?

June 17, 2021

Dr. Michael Fulks, Consulting Medical Director to CRL, comments on the 2020 leading causes of death in a COVID-19 world…. Read More

Tags: Cancer, Covid 19, Heart Disease, Life Insurance, Mortality

Urine Protein Tests: A Mortality Predictor in Life Insurance Populations

March 31, 2021

Urine protein tests offer a simple way for insurance companies to obtain an important predictor of life risk. CRL recently… Read More

Tags: Healthcare, Kidney, Life Insurance, Medical Research, Mortality

COVID-19 Antibody Prevelance Increased throughout 2020: New Research from CRL

January 7, 2021

Dr. Robert Stout, Co-Founder and Chief Scientific Officer at CRL, and Dr. Steven Rigatti, Consulting Medical Director with CRL, conducted… Read More

Tags: Coronavirus, Covid 19, Covid 19 Crisis, Life Insurance, Risk Management

CRL Acquires Confirm BioSciences

December 14, 2020

See below for details on the latest CRL acquisition. We are pleased to share that CRL has acquired¬†Confirm BioSciences, a… Read More

Tags: Acquisition, Business, Laboratory, Life Insurance, Mortality

Are You Overpricing Applicants with HbA1c Elevations?

November 11, 2020

There are many articles that can help answer the question of applicant hemoglobin A1c values, including this study from CRL:¬†Relationship… Read More

Tags: Diabetes, Diabetic, Life Insurance, Mortality, Underwriting

Epigenetics White Paper on Technology & Innovation: CRL Doctor Expertise

November 4, 2020

Dr. Heather Fehling, Chief Scientific Officer of Molecular Diagnostics at CRL, was honored to join the Society of Actuaries Epigenetics… Read More

Tags: Epigenetics, Genetics, Life Insurance, Mortality, Science

Simple Lab Tests May Still Offer the Best Underwriting Protection

October 7, 2020

Dr. Michael Fulks, MD, comments on earlier research regarding the relative mortality in apparently healthy adults with various urine protein/creatinine… Read More

Tags: Lab Tests, Life Insurance, Mortality, Underwriting, Urinalysis